Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY: CC )

14.55 +0.86 (+6.24%)
Streaming Delayed Price Updated: 12:10 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company (The) Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
The Chemours Company Announces Date for Thermal & Specialized Solutions Investor Webinar
From The Chemours Company
Via Business Wire
New Report: Chemours
Chemours' price per share was $32.30 as of Friday's market close. One year ago its price was $29.02. 
Via Talk Markets
Chemours Announces Dates for First Quarter 2022 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
IBD Rating Upgrades: The Chemours Company Flashes Improved Relative Price Strength
The Chemours Company shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Chemours, National Hockey League, and Snider Hockey Partner to Bring a Robust STEM Program to Students at Drexel Neumann Academy
SOURCE: The Chemours Company 
Via 3BL Media
Chemours, National Hockey League, and Snider Hockey Partner to Bring a Robust STEM Program to Students at Drexel Neumann Academy
From The Chemours Company
Via Business Wire
The Chemours Company (NYSE:CC) Shareholder Notice: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 03/14/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of The Chemours Company (NYSE:CC). 
Via SBWire
Chemours Achieves Great Place to Work® Certification in Switzerland
SOURCE: The Chemours Company 
Via 3BL Media
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
Chemours: Q4 Earnings Insights
Chemours (NYSE:CC) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours missed estimated earnings by... 
Via Benzinga
The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook
From The Chemours Company
Via Business Wire
Chemours Appoints Guillaume Pepy to Board of Directors
From The Chemours Company
Via Business Wire
Chemours Announces First Quarter Dividend
From The Chemours Company
Via Business Wire
Methanex Stock Flashing Renewed Strength As Earnings Surge, Near Fresh Buy Point
Among its other key ratings, Methanex stock has a strong 94 Composite Rating, putting it in the top 6% of stocks overall. 
Via Investor's Business Daily
Chemours' CEO Mark Newman Awarded "Culture Builder of the Year" in Technical.ly Awards - Delaware
SOURCE: The Chemours Company 
Via 3BL Media
Chemours Launches School Partnership Program, ChemFEST
SOURCE: The Chemours Company 
Via 3BL Media
3 Stocks That Are Thriving in an Inflationary Environment
The pricing power that these companies boast make them smart stocks to buy with inflation rearing its ugly head in the economy. 
Via InvestorPlace
Chemours Announces Dates for Fourth Quarter 2021 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
Ti-Pure™ Brand Poll Reveals Balancing Sustainability and Cost as Greatest Challenge to Advancing Sustainability in Coatings Product Design
SOURCE: The Chemours Company 
Via 3BL Media
Give A Boost To Your Portfolio With These 4 Top Chemical Stocks
The chemical industry came to a halt last year. However, an increase in manufacturing activity and increased export demand are indicators of the industry’s revival. Thus, we think one could now... 
Via Talk Markets
7 Tech Stocks That Could Rally In December
These tech stocks deserve your attention this holiday season. Here are seven tech stocks that look ready to rise after recent declines. 
Via InvestorPlace
The Chemours Company (CC) Q3 2021 Earnings Call Transcript
CC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Shares in Chemours Soared More Than 10% Today
Value investors have started buying into this unloved sector, even on bad news. 
Via The Motley Fool
Topics Supply Chain
Exposures Supply Chain
3 Model Dividend Growth Portfolios for 3 Different Objectives
A look at three dividend growth portfolios that can be built in today’s generally overvalued market. 
Via Talk Markets
10 Small And Mid-Cap Growth Stocks To Buy Today
If you are looking for long-term growth, you will most likely find it in small and mid-cap stocks because they have the room to grow. The bigger a company gets, the more difficult it is to achieve... 
Via Talk Markets
The Chemours Company (CC) Q2 2021 Earnings Call Transcript
CC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
US Wants To Reclaim Critical Rare Earth Supply Chain
On July 7, Energy Fuels Inc. made its first regular shipment of a rare earth carbonate called monazite from the United States to Europe. The metal started in a mine in southern... 
Via Benzinga
Finding Value In Mid-Cap Stocks
Within the mid-cap space there is something for everyone. 
Via Talk Markets
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.